Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Search Results
Search Results 661 – 680 of 3231
Doravirina
https://clinicalinfo.hiv.gov/drugs/doravirine/patient
Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate
https://clinicalinfo.hiv.gov/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/fda-label
Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate
https://clinicalinfo.hiv.gov/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/patient
Efavirenz / Emtricitabina / Fumarato de disoproxilo de tenofovir
https://clinicalinfo.hiv.gov/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/patient
Efavirenz / Lamivudine / Tenofovir Disoproxil Fumarate
https://clinicalinfo.hiv.gov/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/pt
Efavirenz / Lamivudina / Fumarato de disoproxilo de tenofovir
https://clinicalinfo.hiv.gov/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/pt
Efavirenz
https://clinicalinfo.hiv.gov/drugs/efavirenz/fda-label
Efavirenz
https://clinicalinfo.hiv.gov/drugs/efavirenz/patient
Efavirenz
https://clinicalinfo.hiv.gov/drugs/efavirenz/patient
Elbasvir / Grazoprevir
https://clinicalinfo.hiv.gov/drugs/elbasvir-grazoprevir/fda-label
Elbasvir / Grazoprevir
https://clinicalinfo.hiv.gov/drugs/elbasvir-grazoprevir/patient
Elbasvir / Grazoprevir
https://clinicalinfo.hiv.gov/drugs/elbasvir-grazoprevir/patient
Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide/fda-label
Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide/patient
Elvitegravir / Cobicistat / Emtricitabina / Alafenamida de tenofovir
https://clinicalinfo.hiv.gov/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide/patient
Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Disoproxil Fumarate
https://clinicalinfo.hiv.gov/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate/fda-label
Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Disoproxil Fumarate
https://clinicalinfo.hiv.gov/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate/patient
Elvitegravir / Cobicistat / Emtricitabina / Fumarato de disoproxilo de tenofovir
https://clinicalinfo.hiv.gov/drugs/elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate/patient
Emtricitabine / Rilpivirine / Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/emtricitabine-rilpivirine-tenofovir-alafenamide/fda-label
Emtricitabine / Rilpivirine / Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/emtricitabine-rilpivirine-tenofovir-alafenamide/patient

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Current page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • …
  • Next page ›
  • Last page »

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.